3 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital

2. Mirati Therapeutics, Inc. (NASDAQ:MRTX)

SilverArc Capital’s Stake Value: $3.8 million

Mirati Therapeutics Inc. (NASDAQ:MRTX) is a clinical-stage targeted oncology company with a mission to discover, design and deliver breakthrough therapies.

At the end of the fourth quarter of 2021, 46 hedge funds in the database of Insider Monkey held stakes worth in the company.